?
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Consort Medical plc |
2 Reason for the notification (please tick the appropriate box or boxes): | ||
An acquisition or disposal of voting rights | X | |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||
An event changing the breakdown of voting rights | ||
Other (please specify): | ||
3. Full name of person(s) subject to the notification obligation: | Aviva plc and its subsidiaries |
4. Full name of shareholder(s)(if different from 3.): | Registered Holder: BNY (Nominees) Limited 15,482* BNY Norwich Union Nominees Ltd 155,489* Chase (GA Group) Nominees Limited 962,499* Chase Nominees Limited 32,337* Vidacos Nominees Limited 11,802* * denotes direct interest |
5. Date of the transaction and date on which the threshold is crossed or reached: | 15 January 2013 |
6. Date on which issuer notified: | 16 January 2013 |
7. Threshold(s) that is/are crossed or reached: | 3% to 4% Change at Direct Interest Level |
8. Notified details: | |||||||
A: Voting rights attached to shares | |||||||
Class/type of
|
Situation previous | Resulting situation after the triggering transaction | |||||
Number |
Number |
Number |
Number of voting | % of voting rights | |||
Direct | Direct | Indirect | Direct | Indirect | |||
GB0000946276 | 1,156,625 | 1,156,625 | 1,177,609 | 1,177,609 | Not Disclosable | 4.03% | Not Disclosable |
B: Qualifying Financial Instruments | ||||
Resulting situation after the triggering transaction | ||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financial |
Exercise |
Expiration |
Exercise/ |
Number of voting | % of voting rights | |
Nominal | Delta |
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
1,177,609 | 4.03% |
9. Chain of controlled undertakings through which the voting rights and/or the |
The voting rights are managed and controlled by Aviva Investors Global Services Limited with the following chain of controlled undertakings: Aviva Investors Global Services Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Plc) · Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) |
Proxy Voting: | |
10. Name of the proxy holder: | See Section 4 |
11. Number of voting rights proxy holder will cease to hold: | |
12. Date on which proxy holder will cease to hold voting rights: |
13. Additional information: | Figures are based on a total number of voting rights of 29,201,914 as per TVR announcement on 3 January 2013 |
14. Contact name: | John Slater Company Secretary |
15. Contact telephone number: | 01442 867920 |
This information is provided by RNS
RNS news service provided by Hemscott Group Limited.
distributed by |